Endocrine, Diabetes and Bone Diseases (Endocrinology)
Endocrine, Diabetes and Bone Diseases (Endocrinology)
Research
Dr. Tamler's PhD research focused on free radical
biology, and he is transferring his experience from the bench to the clinical
arena by investigating diabetes-related endothelial dysfunction. He is working
closely with the departments of Urology and Cardiology, studying the effects of
testosterone on endothelial function. He is also involved in several trials
involving bariatric surgery in patients with diabetes. Dr. Tamler has published
extensively on the use of nutritional supplements for hormonal issues in
general and more specifically in men. Finally, Dr. Tamler is a sought-after
expert on mobile health and the use of smart phone applications for diabetes
self-management. He is a frequent speaker at regional, national and
international venues on the topic of men's health and diabetes. He has
also been involved in several trials involving bariatric surgery in patients
with diabetes and with abnormal sex hormone profile.
Dr. Tamler is involved with clinical trials at
the Mount Sinai Diabetes Center. There are numerous clinical trials that are
ongoing or in preparation at any point in time. If you are interested
in learning more about our trials, feel free to contact Dr. Tamler at
212-241-3422.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tamler has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tamler has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.